Researchers have discovered a way to effectively deliver staurosporine (STS), a powerful anti-cancer compound that has vexed researchers for more than 30 years due to its instability in the blood and toxic nature in both healthy and cancerous cells.
The research took place at the University of California, San Diego School of Medicine. For the first time, the new method safely delivered STS to mouse tumors, suppressing them with no apparent side effects. The results were published online, October 20, in the International Journal of Nanomedicine.
Scientists Identify Gene Variant That Ups Risk of Colorectal Cancer from Eating Red Meat
A common genetic variant that affects 1 in 3 people significantly increases the risk of colorectal cancer from the consumption of red meat and processed meat has been discovered by scientists.
Advertisement
"By itself, staurosporine shows potent activity against a number of cancer cell lines, including chemotherapy-resistant tumors. However, it also harms normal tissue," said senior author Santosh Kesari, MD, PhD, director of neuro-oncology at UC San Diego Moores Cancer Center. "With this study, we have been able to overcome the pharmacokinetic barriers to delivering staurosporine to tumors with the use of liposomes."
STS was originally isolated from the bacterium Streptomyces staurosporeus in 1977. The compound prompts a wide variety of cancer cell types to self-destruct, a process called apoptosis or programmed cell death. In its free form, STS is quickly metabolized and harmful to healthy cells. By trapping STS in tiny spheres called liposomes, Moores Cancer Center researchers have been able to effectively deliver the compound, past healthy tissue, to the tumor, with potent results.
![Researchers Develop New Idea for Targeting the Common Cancer Protein KRAS]( "Researchers Develop New Idea for Targeting the Common Cancer Protein KRAS")
Study finds patients with cancers driven by the protein KRAS, may benefit from small molecules that attach to and disrupt the function of a KRAS-containing protein complex.
Liposomes are microscopic bubbles made from the same molecules as cell membranes. Researchers use these hollow spheres to deliver therapeutic agents. Anti-cancer drugs can be loaded inside, while disguising agents coat the external membrane surface to hide the cancer-killer from the immune system.
Source: Eurekalert
Researchers Develop New Idea for Targeting the Common Cancer Protein KRAS
Study finds patients with cancers driven by the protein KRAS, may benefit from small molecules that attach to and disrupt the function of a KRAS-containing protein complex.
Advertisement
Liposomes are microscopic bubbles made from the same molecules as cell membranes. Researchers use these hollow spheres to deliver therapeutic agents. Anti-cancer drugs can be loaded inside, while disguising agents coat the external membrane surface to hide the cancer-killer from the immune system.
Source: Eurekalert
Diabetes Drug Along With Chemo and Radiation may Improve Outcomes in Lung Cancer Patients
Metformin along with radiation and chemotherapy may slow lung tumor growth and recurrence, suggests study.
Advertisement
 Coffee Consumption Cuts Liver Cancer RiskThree cups of coffee per day can reduce the risk of hepatocellular carcinoma (HCC) by more than 50 percent, reveals study. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
New study sheds light on the intrinsic, yet often overlooked, role of sleep preparation as a hardwired survival strategy.
Microgravity-induced bone loss in space, can be reduced by systemic delivery of NELL-1, a protein required for bone growth and its maintenance.
Researchers establish connections between Alzheimer's-linked genetic alterations and the functioning of brain cells.
Team at NeuroRestore introduces a groundbreaking gene therapy that has effectively promoted nerve regrowth and reconnection, post spinal cord injury.
Scientists aim to pinpoint particular functional pathways affected by these bacteria that may have an impact on skeletal health.
